BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lankhorst CE, Wish JB. Anemia in renal disease: diagnosis and management. Blood Rev. 2010;24:39-47. [PMID: 19833421 DOI: 10.1016/j.blre.2009.09.001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Ghasemi F, Abdi A, Salari N, Tohidi MR, Faraji A. Comparing the effects of intravenous and subcutaneous Erythropoietin on blood indices in hemodialysis patients. Sci Rep 2019;9:2284. [PMID: 30783118 DOI: 10.1038/s41598-018-38193-z] [Reference Citation Analysis]
2 Barbieri C, Mari F, Stopper A, Gatti E, Escandell-montero P, Martínez-martínez JM, Martín-guerrero JD. A new machine learning approach for predicting the response to anemia treatment in a large cohort of End Stage Renal Disease patients undergoing dialysis. Computers in Biology and Medicine 2015;61:56-61. [DOI: 10.1016/j.compbiomed.2015.03.019] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
3 Zhu XW, Zhang CX, Xu TH, Jiang GN, Yao L. Efficacy of roxadustat in treatment of peritoneal dialysis patients with renal anaemia. World J Clin Cases 2021; 9(26): 7682-7692 [PMID: 34621819 DOI: 10.12998/wjcc.v9.i26.7682] [Reference Citation Analysis]
4 Zhang R, Wang SY, Yang F, Ma S, Lu X, Kan C, Zhang JB. Crosstalk of fibroblast growth factor 23 and anemia-related factors during the development and progression of CKD (Review). Exp Ther Med 2021;22:1159. [PMID: 34504604 DOI: 10.3892/etm.2021.10593] [Reference Citation Analysis]
5 Yugavathy N, Huri HZ, Kun LS, Bin Abdul Gafor AH, Geot WM, Bavanandan S, Seng WH. Clinical and genetic markers of erythropoietin deficiency anemia in chronic kidney disease (predialysis) patients. Biomark Med 2020;14:1099-108. [PMID: 32969247 DOI: 10.2217/bmm-2020-0205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Feng S, Chang S, Yan L, Dong H, Xu X, Wang C, Liang Y, Liu K. Design, synthesis, and activity evaluation of novel erythropoietin mimetic peptides. Bioorg Med Chem Lett 2018;28:3038-41. [PMID: 30097369 DOI: 10.1016/j.bmcl.2018.08.004] [Reference Citation Analysis]
7 Bowry SK, Gatti E. Impact of Hemodialysis Therapy on Anemia of Chronic Kidney Disease: The Potential Mechanisms. Blood Purif 2011;32:210-9. [DOI: 10.1159/000329573] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
8 Pancha Mbouemboue O, Danbe OD, Tangyi Tamanji M, Ngoufack JO. Frequency of Specific Cardiovascular Disease Risk Factors among Cameroonian Patients on Dialysis: The Cases of Anaemia, Inflammation, Phosphate, and Calcium. Cardiol Res Pract 2016;2016:5031927. [PMID: 27313944 DOI: 10.1155/2016/5031927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Gupta N, Wish JB. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD. Am J Kidney Dis 2017;69:815-26. [PMID: 28242135 DOI: 10.1053/j.ajkd.2016.12.011] [Cited by in Crossref: 164] [Cited by in F6Publishing: 156] [Article Influence: 32.8] [Reference Citation Analysis]
10 Buckley MS, Kane-gill SL, Patel SA. Clinical and Economic Evaluation of an Evidence-Based Institutional Epoetin-Utilization Management Program. Clinical Therapeutics 2013;35:294-302. [DOI: 10.1016/j.clinthera.2013.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
11 Canavesi E, Alfieri C, Pelusi S, Valenti L. Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease. World J Nephrol 2012; 1(6): 166-176 [PMID: 24175256 DOI: 10.5527/wjn.v1.i6.166] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
12 Xu Y, Ding XQ, Zou JZ, Liu ZH, Jiang SH, Chen YM. Serum hepcidin in haemodialysis patients: associations with iron status and microinflammation. J Int Med Res 2011;39:1961-7. [PMID: 22118000 DOI: 10.1177/147323001103900542] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
13 Tonon J, Guarnier FA, Cecchini AL, Cecchini R. Anemia associated with extraerythrocytic oxidative stress damage mediated by neutrophil superoxide anion production in chronic renal failure patients undergoing hemodialysis. Pathophysiology 2012;19:261-8. [DOI: 10.1016/j.pathophys.2012.07.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
14 Trkulja V. Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices. Med Hypotheses 2012;78:157-61. [PMID: 22078846 DOI: 10.1016/j.mehy.2011.10.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
15 Zhang H, Huang Z, He L, Yuan F, Sun L, Liu F, Xiao L. Successful treatment of anti-EPO antibody associated refractory anemia with hypoxia-inducible factor prolyl hydroxylase inhibitor. Ren Fail 2020;42:860-4. [PMID: 32814474 DOI: 10.1080/0886022X.2020.1803087] [Reference Citation Analysis]
16 Mallet RT, Ryou MG. Erythropoietin: Endogenous Protection of Ischemic Brain. Vitam Horm 2017;105:197-232. [PMID: 28629519 DOI: 10.1016/bs.vh.2017.01.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
17 Afroozeh A, Innate K, Ali J, Yupapin P. THz frequency generation using Gaussian pulse for medical applications. Optik 2013;124:416-9. [DOI: 10.1016/j.ijleo.2011.12.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
18 Fibach E. Involvement of phosphatases in proliferation, maturation, and hemoglobinization of developing erythroid cells. J Signal Transduct 2011;2011:860985. [PMID: 21785724 DOI: 10.1155/2011/860985] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
19 Chuengsaman P, Narenpitak S, Sritippayawan S. Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis. World J Nephrol 2021; 10(6): 109-121 [PMID: 34909408 DOI: 10.5527/wjn.v10.i6.109] [Reference Citation Analysis]
20 Pereira A, Midão L, Almada M, Costa E. Pre-Frailty and Frailty in Dialysis and Pre-Dialysis Patients: A Systematic Review of Clinical and Biochemical Markers. Int J Environ Res Public Health 2021;18:9579. [PMID: 34574503 DOI: 10.3390/ijerph18189579] [Reference Citation Analysis]
21 Butler LM, Dzabic M, Bakker F, Davoudi B, Jeffery H, Religa P, Bojakowski K, Yaiw KC, Rahbar A, Söderberg-Naucler C. Human cytomegalovirus inhibits erythropoietin production. J Am Soc Nephrol 2014;25:1669-78. [PMID: 24722450 DOI: 10.1681/ASN.2013101125] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
22 Hou YP, Mao XY, Wang C, Xu ZH, Bu ZH, Xu M, Li B. Roxadustat treatment for anemia in peritoneal dialysis patients: A randomized controlled trial. J Formos Med Assoc 2021:S0929-6646(21)00250-3. [PMID: 34167878 DOI: 10.1016/j.jfma.2021.06.004] [Reference Citation Analysis]
23 Ajmal F, Probst JC, Brooks JM, Hardin JW, Qureshi Z, Jafar TH. Freestanding Dialysis Facility Quality Incentive Program Scores and Mortality Among Incident Dialysis Patients in the United States. Am J Kidney Dis 2020;75:177-86. [PMID: 31685294 DOI: 10.1053/j.ajkd.2019.07.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
24 Hwang HS, Song YM, Kim EO, Koh ES, Yoon HE, Chung SJ, Lee SJ, Chang YK, Yang CW, Chang YS, Kim SY. Decisive indicator for gastrointestinal workup in anemic patients with nondialysis chronic kidney disease. Int J Med Sci 2012;9:634-41. [PMID: 23055815 DOI: 10.7150/ijms.4969] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
25 Honda H, Kobayashi Y, Onuma S, Shibagaki K, Yuza T, Hirao K, Yamamoto T, Tomosugi N, Shibata T. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis. PLoS One 2016;11:e0151601. [PMID: 26978524 DOI: 10.1371/journal.pone.0151601] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
26 Chambellan A, Coulon S, Cavailles A, Hermine O, Similowski T. BPCO et érythropoïèse : interactions et conséquences. Revue des Maladies Respiratoires 2012;29:213-31. [DOI: 10.1016/j.rmr.2011.12.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
27 Pesce M, Felaco P, Franceschelli S, Speranza L, Grilli A, De Lutiis MA, Ferrone A, Sirolli V, Bonomini M, Felaco M, Patruno A. Effect of erythropoietin on primed leucocyte expression profile. Open Biol 2014;4:140026. [PMID: 24920275 DOI: 10.1098/rsob.140026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
28 Mikhail A. Profile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysis. J Blood Med 2012;3:25-31. [PMID: 22719216 DOI: 10.2147/JBM.S23270] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
29 Guidi GC, Lechi Santonastaso C. Advancements in anemias related to chronic conditions. Clin Chem Lab Med 2010;48:1217-26. [PMID: 20618092 DOI: 10.1515/CCLM.2010.264] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
30 Wong HS, Chang CM, Kao CC, Hsu YW, Liu X, Chang WC, Wu MS, Chang WC. V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients. J Biomed Sci 2017;24:43. [PMID: 28697735 DOI: 10.1186/s12929-017-0349-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
31 Santos-Silva A, Ribeiro S, Reis F, Belo L. Hepcidin in chronic kidney disease anemia. Vitam Horm 2019;110:243-64. [PMID: 30798815 DOI: 10.1016/bs.vh.2019.01.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
32 Mahmoud T, Borgi L. The Interplay Between Nutrition, Metabolic, and Endocrine Disorders in Chronic Kidney Disease. Semin Nephrol 2021;41:180-8. [PMID: 34140096 DOI: 10.1016/j.semnephrol.2021.03.012] [Reference Citation Analysis]
33 Urrechaga E, Borque L, Escanero JF. Biomarkers of hypochromia: the contemporary assessment of iron status and erythropoiesis. Biomed Res Int 2013;2013:603786. [PMID: 23555091 DOI: 10.1155/2013/603786] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
34 Kouegnigan Rerambiah L, Essola Rerambiah L, Mbourou Etomba A, Mouguiama RM, Issanga PB, Biyoghe AS, Batchilili B, Akone Assembe S, Djoba Siawaya JF. Blood transfusion, serum ferritin, and iron in hemodialysis patients in Africa. J Blood Transfus 2015;2015:720389. [PMID: 25685597 DOI: 10.1155/2015/720389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Yilmaz H, Cakmak M, Darcin T, Inan O, Bilgic MA, Bavbek N, Akcay A. Can Serum Gdf-15 be Associated with Functional Iron Deficiency in Hemodialysis Patients? Indian J Hematol Blood Transfus 2016;32:221-7. [PMID: 27065587 DOI: 10.1007/s12288-015-0551-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
36 Valliant A, Hofmann RM. Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide. Int J Nanomedicine 2013;8:3297-307. [PMID: 24023516 DOI: 10.2147/IJN.S44944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
37 Hueso M, Vellido A, Montero N, Barbieri C, Ramos R, Angoso M, Cruzado JM, Jonsson A. Artificial Intelligence for the Artificial Kidney: Pointers to the Future of a Personalized Hemodialysis Therapy. Kidney Dis (Basel) 2018;4:1-9. [PMID: 29594137 DOI: 10.1159/000486394] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
38 Leung N. Hematologic manifestations of kidney disease. Semin Hematol 2013;50:207-15. [PMID: 23953337 DOI: 10.1053/j.seminhematol.2013.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
39 Wheeler JA, Clinkenbeard EL. Regulation of Fibroblast Growth Factor 23 by Iron, EPO, and HIF. Curr Mol Biol Rep 2019;5:8-17. [PMID: 31218207 DOI: 10.1007/s40610-019-0110-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
40 Fukuma S, Shimizu S, Niihata K, Sada KE, Yanagita M, Hatta T, Nangaku M, Katafuchi R, Fujita Y, Koizumi J, Koizumi S, Kimura K, Fukuhara S, Shibagaki Y. Development of quality indicators for care of chronic kidney disease in the primary care setting using electronic health data: a RAND-modified Delphi method. Clin Exp Nephrol 2017;21:247-56. [PMID: 27145768 DOI: 10.1007/s10157-016-1274-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
41 Garrido P, Ribeiro S, Fernandes J, Vala H, Rocha-Pereira P, Bronze-da-Rocha E, Belo L, Costa E, Santos-Silva A, Reis F. Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia. Int J Mol Sci 2015;17:E28. [PMID: 26712750 DOI: 10.3390/ijms17010028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
42 Wittwer I. Iron deficiency anaemia in chronic kidney disease. J Ren Care 2013;39:182-8. [PMID: 23911105 DOI: 10.1111/j.1755-6686.2013.12026.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
43 Boutou A, Hopkinson N, Polkey M. Anaemia in chronic obstructive pulmonary disease: an insight into its prevalence and pathophysiology. Clinical Science 2015;128:283-95. [DOI: 10.1042/cs20140344] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
44 Attanasio P, Ronco C, Anker SD, Cicoira M, von Haehling S. Role of iron deficiency and anemia in cardio-renal syndromes. Semin Nephrol 2012;32:57-62. [PMID: 22365163 DOI: 10.1016/j.semnephrol.2011.11.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]